Author name: systems

Global Major Depressive Disorder (MDD) Treatment Market Major depressive disorder (MDD), also known as clinical depression, is a mental health disorder which affects mood, behavior, as well as appetite and sleep. The exact cause of MDD is not known; however, several factors that can potentially increase its risk include a combination of genes and stress […]

NEW YORK and TOKYO, March 16, 2021 /PRNewswire/ — Perception Neuroscience (Perception), an atai Life Sciences (atai) company focused on developing innovative therapies in neuropsychiatric disorders, and Otsuka Pharmaceutical Co., Ltd. (Otsuka), announce a collaboration and licensing agreement for the development and commercialization of Perception’s lead molecule, PCN-101 (R-ketamine) in Japan as a potential treatment

Our bodies produce different scents when we feel happy or afraid. These so-called chemosignals – which are in fact odourless – are believed to trigger happiness or fear in others. It is one of the ways smell impacts people’s social interactions. ‘It’s like an emotional contagion. If I feel fear, my body odour will be

Courtesty: Taylor Helmes Taylor Helmes was first diagnosed as having severe depression a decade ago as a community college student. Through hard work and therapy, she poised to graduate from California State University, Dominguez Hills in May. Courtesty: Taylor Helmes Taylor Helmes was first diagnosed as having severe depression a decade ago as a community

Newswise — Exercise has long-been recommended as a cognitive-behavioral therapy for patients of depression, yet new evidence from the University of California of San Diego suggests that the COVID-19 pandemic changed the nature of the relationship between physical activity and mental health. In a study of college students conducted before and during the pandemic, findings

Multiple brain networks contributed to the pathophysiology of major depressive disorder (MDD) including disruption of the information processing system. These findings, from an analysis of functional magnetic resonance imaging (fMRI) data, were published in the Journal of Affective Disorders. Patients (n=753) with MDD and healthy controls (n=451) were recruited from 14 hospitals in China. Participants

Families are noticing a regression in loved one with Dementia. Experts say isolation, lack of socialization and change in routine are all contributing factors. KNOXVILLE, Tenn. — The pandemic is having a negative effect on people with Alzheimer’s and Dementia. Experts on the disease say they are now seeing more depression and anxiety with those

Roman Kemp on feeling ‘trapped’ by depression  BBC Three

Beta-blockers (medications that reduce your blood pressure) treat various cardiovascular diseases and were not more likely to cause depression compared to other similar treatments, according to new research. The research was published today in Hypertension, an American Heart Association journal. While depression may occur during beta-blocker therapy, the research suggests beta-blockers are not the likely

Not everyone responds to conventional antidepressants. (Posed by a model, Getty Images) A hallucinogenic drug is being trialled as a potential treatment for depression. So-called n, n-dimethyltryptamine (DMT) – known for its use in shamanic rituals – is being offered to a group of people with a moderate to severe case of the mental illness.